These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22564068)

  • 1. Understanding chronic inflammatory and neuropathic pain.
    Hughes JP; Chessell I; Malamut R; Perkins M; Bačkonja M; Baron R; Farrar JT; Field MJ; Gereau RW; Gilron I; McMahon SB; Porreca F; Rappaport BA; Rice F; Richman LK; Segerdahl M; Seminowicz DA; Watkins LR; Waxman SG; Wiech K; Woolf C
    Ann N Y Acad Sci; 2012 May; 1255():30-44. PubMed ID: 22564068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.
    Taneja A; Della Pasqua O; Danhof M
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antineuropathic medications for the treatment of chronic pain.
    Urits I; Li N; Berardino K; Artounian KA; Bandi P; Jung JW; Kaye RJ; Manchikanti L; Kaye AM; Simopoulos T; Kaye AD; Torres M; Viswanath O
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):493-506. PubMed ID: 33004161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and clinical management of pain.
    Stump PR; Dalben Gda S
    Braz Oral Res; 2012; 26 Suppl 1():115-9. PubMed ID: 23318753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial.
    de Leeuw TG; Mangiarini L; Lundin R; Kaguelidou F; van der Zanden T; Pasqua OD; Tibboel D; Ceci A; de Wildt SN;
    Trials; 2019 Jan; 20(1):49. PubMed ID: 30646965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.
    Kamrul R; Bunka D; Crawley A; Schuster B; LeBras M
    Can Fam Physician; 2019 Nov; 65(11):807-811. PubMed ID: 31722915
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular and molecular mechanisms driving neuropathic pain: recent advancements and challenges.
    Fernandes V; Sharma D; Vaidya S; P A S; Guan Y; Kalia K; Tiwari V
    Expert Opin Ther Targets; 2018 Feb; 22(2):131-142. PubMed ID: 29285962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronobiology of chronic pain: focus on diurnal rhythmicity of neuropathic pain.
    Gilron I; Ghasemlou N
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):429-36. PubMed ID: 25111256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotherapy of chronic neuropathic pain].
    Otto J; Forstenpointner J; Binder A; Baron R
    Internist (Berl); 2019 Jul; 60(7):711-723. PubMed ID: 31187164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane Stabilizer Medications in the Treatment of Chronic Neuropathic Pain: a Comprehensive Review.
    Viswanath O; Urits I; Jones MR; Peck JM; Kochanski J; Hasegawa M; Anyama B; Kaye AD
    Curr Pain Headache Rep; 2019 May; 23(6):37. PubMed ID: 31044330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Cannabis for Neuropathic Pain.
    Lee G; Grovey B; Furnish T; Wallace M
    Curr Pain Headache Rep; 2018 Feb; 22(1):8. PubMed ID: 29388063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management.
    Widerström-Noga E
    Drugs; 2017 Jun; 77(9):967-984. PubMed ID: 28451808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathic and non-neuropathic chronic pain at GP encounters: Prevalence, patient characteristics, suffering and pregabalin use.
    Henderson J; Pollack AJ; Pan Y; Miller GC
    Aust Fam Physician; 2016 Nov; 45(11):783-786. PubMed ID: 27806445
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
    Sandrini G; De Icco R; Tassorelli C; Smania N; Tamburin S
    J Headache Pain; 2017 Dec; 18(1):38. PubMed ID: 28324318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food-Derived Natural Compounds for Pain Relief in Neuropathic Pain.
    Lim EY; Kim YT
    Biomed Res Int; 2016; 2016():7917528. PubMed ID: 27891521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future directions in the treatment of neuropathic pain: a review on various therapeutic targets.
    Gangadhar M; Mishra RK; Sriram D; Yogeeswari P
    CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):63-81. PubMed ID: 24152326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Whether or not to use gabapentinoids in adults with chronic neuropathic pain].
    van Poelgeest EP; El Houssein L; Kallewaard J; Hollmann MW; Steegers MAH; Wartenberg HCH
    Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of chronic neuropathic pain of different causes with the combination of oral methadone along with ketamine: A report of 18 cases.
    de Godoy MC; Dalmolin GD; Rigo FK; Rossato MF; de Menezes MS; Alvarez MA; Hernandes JJ; Moreno LA; Sinche M; Ferreira J
    Eur J Anaesthesiol; 2013 Oct; 30(10):638-40. PubMed ID: 23624745
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and management of neuropathic pain.
    Wong CS; Hui GK; Chung EK; Wong SH
    Pain Manag; 2014 May; 4(3):221-31. PubMed ID: 24953074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated Guideline of the Canadian Pain Society for the pharmacological management of chronic neuropathic pain: Does it bring something new?
    Alcántara Montero A; Sánchez Carnerero CI
    Rev Esp Anestesiol Reanim (Engl Ed); 2018; 65(6):356-358. PubMed ID: 29426623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.